Mukaremera L, Nielsen K
J Fungi (Basel). 2018; 3(4).
PMID: 29333430
PMC: 5753166.
DOI: 10.3390/jof3040064.
Srikanta D, Santiago-Tirado F, Doering T
Yeast. 2013; 31(2):47-60.
PMID: 24375706
PMC: 3938112.
DOI: 10.1002/yea.2997.
Srikanta D, Yang M, Williams M, Doering T
PLoS One. 2011; 6(7):e22773.
PMID: 21829509
PMC: 3145667.
DOI: 10.1371/journal.pone.0022773.
Voelz K, May R
Eukaryot Cell. 2010; 9(6):835-46.
PMID: 20382758
PMC: 2901644.
DOI: 10.1128/EC.00039-10.
Kelly R, Chen J, Yauch L, Levitz S
Infect Immun. 2004; 73(1):592-8.
PMID: 15618199
PMC: 539000.
DOI: 10.1128/IAI.73.1.592-598.2005.
Monoclonal antibodies reactive with immunorecessive epitopes of glucuronoxylomannan, the major capsular polysaccharide of Cryptococcus neoformans.
Brandt S, Thorkildson P, Kozel T
Clin Diagn Lab Immunol. 2003; 10(5):903-9.
PMID: 12965925
PMC: 193905.
DOI: 10.1128/cdli.10.5.903-909.2003.
Contribution of epitope specificity to the binding of monoclonal antibodies to the capsule of Cryptococcus neoformans and the soluble form of its major polysaccharide, glucuronoxylomannan.
Duro R, Netski D, Thorkildson P, Kozel T
Clin Diagn Lab Immunol. 2003; 10(2):252-8.
PMID: 12626451
PMC: 150530.
DOI: 10.1128/cdli.10.2.252-258.2003.
Acute lethal toxicity following passive immunization for treatment of murine cryptococcosis.
Savoy A, Lupan D, Manalo P, Roberts J, Schlageter A, Weinhold L
Infect Immun. 1997; 65(5):1800-7.
PMID: 9125564
PMC: 175220.
DOI: 10.1128/iai.65.5.1800-1807.1997.
Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry.
Chaka W, Scharringa J, Verheul A, Verhoef J, Van Strijp A, Hoepelman I
Clin Diagn Lab Immunol. 1995; 2(6):753-9.
PMID: 8574842
PMC: 170233.
DOI: 10.1128/cdli.2.6.753-759.1995.
Prevalence in Cryptococcus neoformans strains of a polysaccharide epitope which can elicit protective antibodies.
Cleare W, Mukherjee S, Spitzer E, Casadevall A
Clin Diagn Lab Immunol. 1994; 1(6):737-40.
PMID: 8556529
PMC: 368405.
DOI: 10.1128/cdli.1.6.737-740.1994.
Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection.
Mukherjee J, Pirofski L, Scharff M, Casadevall A
Proc Natl Acad Sci U S A. 1993; 90(8):3636-40.
PMID: 8475112
PMC: 46356.
DOI: 10.1073/pnas.90.8.3636.
Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization.
Mukherjee J, Casadevall A, Scharff M
J Exp Med. 1993; 177(4):1105-16.
PMID: 8459205
PMC: 2190969.
DOI: 10.1084/jem.177.4.1105.
Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B.
Mukherjee J, Zuckier L, Scharff M, Casadevall A
Antimicrob Agents Chemother. 1994; 38(3):580-7.
PMID: 8203858
PMC: 284501.
DOI: 10.1128/AAC.38.3.580.
Monoclonal antibodies to Cryptococcus neoformans capsular polysaccharide modify the course of intravenous infection in mice.
Mukherjee S, Lee S, Mukherjee J, Scharff M, Casadevall A
Infect Immun. 1994; 62(3):1079-88.
PMID: 8112842
PMC: 186227.
DOI: 10.1128/iai.62.3.1079-1088.1994.
Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan.
Houpt D, Pfrommer G, Young B, Larson T, Kozel T
Infect Immun. 1994; 62(7):2857-64.
PMID: 8005676
PMC: 302892.
DOI: 10.1128/iai.62.7.2857-2864.1994.
Mouse-human immunoglobulin G1 chimeric antibodies with activities against Cryptococcus neoformans.
Zebedee S, Koduri R, Mukherjee J, Mukherjee S, Lee S, Sauer D
Antimicrob Agents Chemother. 1994; 38(7):1507-14.
PMID: 7979280
PMC: 284584.
DOI: 10.1128/AAC.38.7.1507.
Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell.
Mukherjee J, Nussbaum G, Scharff M, Casadevall A
J Exp Med. 1995; 181(1):405-9.
PMID: 7807020
PMC: 2191853.
DOI: 10.1084/jem.181.1.405.
Antibody immunity and invasive fungal infections.
Casadevall A
Infect Immun. 1995; 63(11):4211-8.
PMID: 7591049
PMC: 173598.
DOI: 10.1128/iai.63.11.4211-4218.1995.
Immunity in cryptococcosis: an overview.
Fromtling R, Shadomy H
Mycopathologia. 1982; 77(3):183-90.
PMID: 7040977
DOI: 10.1007/BF00518804.
Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils.
Kozel T, Highison B, Stratton C
Infect Immun. 1984; 43(2):574-9.
PMID: 6363293
PMC: 264336.
DOI: 10.1128/iai.43.2.574-579.1984.